Eton Pharmaceuticals, Inc. · NASDAQ:ETON

Krempa David exercised options for 10,000 Eton Pharmaceuticals, Inc. shares (Form 4)

Traded Jul 12, 2026 · Filed Jul 13, 2026

On Jul 12, 2026, Krempa David (Chief Business Officer) exercised options for 10,000 Eton Pharmaceuticals, Inc. shares, leaving 37,025 shares. Filed Jul 13, 2026 (Form 4).

Options exercised
10,000 shares
Holding after
37,025 shares
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 12, 2026Common StockOption exercise10,00037,025Direct

Source

View original at SEC

Related